Form 4: Health Catalyst Executive Linda Llewelyn Sells Shares Under 10b5-1 Plan

Linda Llewelyn, Chief People Officer of Health Catalyst, Inc., sold 1,324 shares of common stock at $8.43 per share on September 16, 2024, under a pre-arranged trading plan.

Summary

• On September 16, 2024, Linda Llewelyn, the Chief People Officer of Health Catalyst, Inc. (HCAT), sold 1,324 shares of the company's common stock.
• The sale was executed at a price of $8.43 per share.
• This transaction was conducted under a pre-arranged trading plan adopted on March 12, 2024, in accordance with Rule 10b5-1.
• Following the transaction, Llewelyn directly owns 115,599 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction was conducted under a pre-arranged trading plan, suggesting it was not based on current insider knowledge of the company's performance.

Industry Context

Insider transactions are routinely monitored by investors to gauge executive sentiment regarding the company's performance and future prospects. Sales, even under pre-arranged plans, can sometimes be interpreted negatively, although 10b5-1 plans are designed to avoid such implications.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates potential concerns.

Key Dates